UF Health Cancer Institute Protocol Activation Guide
A Sponsor’s Guide to Initiating Clinical Trials at the UF Health Cancer Center

Protocol Activation Process at a Glance

An orange and blue flowchart graphic.

Guidelines

The email listserv for the Protocol Activation Team is Protocol_activation@cancer.ufl.edu. Once a Protocol Activation Coordinator (PAC) has been assigned, they should be included in all correspondence until study activation to ensure smooth and efficient processing. Emails sent to the PAC or listserv should receive a response within 24 to 48 business hours.

Please note that some details may vary slightly depending on the complexity of the study; however, the processes and guidelines outlined here represent the typical expectations for protocol activation. Information on this page is meant for use by study sponsors engaged with the UF Health Cancer Institute for study activation and is meant to be confidential.

Acronyms and committees

  • BSC: BioSafety Committee, responsible for establishing, monitoring, and enforcing policies and procedures for work involving biohazardous materials and/or recombinant DNA molecules (in accordance with NIH guidelines)
  • CRH: Clinical Research Hub, responsible for initial QA of the Medicare Coverage Analysis and final financial QA prior to activation
  • DSG: Disease Site Group, responsible for initial review and endorsement of opening the trial at UF
  • DSP: Division of Sponsored Programs, responsible for contracting. The budget must be finalized and MCA must be reviewed by CRH contracting can begin
  • HURRC: HUman Radioisotope and Radiation Committee, responsible for review of radiological procedures that are administered solely for experimental or research, use of an investigational radiological device or investigational radiopharmaceutical, and use of radiological procedures when these procedures are the subject of the investigation
  • IRB: Institutional Review Board, final review of the study to ensure participants are adequately informed and protected
  • SRMC: Scientific Review and Monitoring Committee, reviews the study prior to IRB submission for scientific rigor and clinical impact

Timelines

The UF Health Cancer Institute is committed to efficient study activation, with a goal of IRB approval within 3 to 5 months of receiving all study documents and manuals. Although the UF Health Cancer Institute does not have a formal accelerated activation process, below are some tips for sponsors to accelerate activation:

Reduce negotiation time:

  • Master contract on file so that contract language is already agreed upon
  • Agree to all site fees as-is

Parallel processing:

  • Allow Site Initiation Visit to occur prior to IRB approval if need arises

Reduce extra administrative tasks:

  • No amendments to be processed during the activation period
  • Provide Medicare Coverage Analysis justifications with the budget

Frequently requested documents

Supporting documentation for institutional fees

Site Evaluation (SEV) Virtual Tours

Other site documents


Commonly Requested Standard Operating Procedures (SOPs) and Policies:

Informed consent

Investigational Pharmacy

Site Visits

Note: All SEVs are conducted remotely. Sponsors are permitted one on-site visit per year, inclusive of the SIV.

Other SOPs and Policies


Our Team

Kiara Barker
Department: HA-UFHCC CRO ADMIN

Kiara Barker MPH

Assistant Director of Clinical Research Administration & Finance
Ashley D Anderson
Department: HA-UFHCC CLINICAL RESEARCH

Ashley D Anderson MBA, ACRP-CP

Assistant Director of Regulatory Affairs & Compliance
Phone: (352) 273-8296

Protocol Activation Coordinators

Benjamin G White
Department: HA-UFHCI CRO SPONSORED PROJS

Benjamin G White

Protocol Activation Manager
Phone: (352) 273-8017
Kellie L Curry
Department: HA-UFHCI CRO SPONSORED PROJS

Kellie L Curry RN, OCN, CCRP

Research Admin III
Phone: (352) 682-3440
Katie M Smith
Department: HA-UFHCC CRO ADMIN

Katie M Smith MPH, ACRP-CP

Protocol Activation Coordinator
Phone: (352) 294-8570
Judy Hugh
Department: HA-UFHCC CRO ADMIN

Judy Hugh

Project Manager I
Phone: (352) 273-8869
Ally Senkarik
Department: HA-UFHCC CRO ADMIN

Ally Senkarik

Protocol Activation Coordinator II
Phone: (352) 273-5341

Finance/Budget/Post-Award Team

David H Veal
Department: HA-UFHCC CRO ADMIN

David H Veal

Budget and Finance Manager
Phone: (352) 273-8102
Leigh A Marshall
Department: HA-UFHCI CRO ADMIN

Leigh A Marshall

Clinical Research Administrator II
Laurie Brown
Department: HA-UFHCI CRO ADMIN

Laurie Brown MBA, CCRC

Clinical Research Administrator II
Phone: (352) 294-8886
Stephanie A Jones
Department: HA-UFHCC CRO ADMIN

Stephanie A Jones

Research Billing Compliance Coordinator
Phone: (352) 273-8018
Maria E Raulerson
Department: HA-UFHCC CRO ADMIN

Maria E Raulerson

Research Billing Compliance Coordinator
Phone: (352) 294-8911

Regulatory Manager

Alexis R Jennings
Department: HA-UFHCI CRO REGULATORY

Alexis R Jennings PhD, MPH

Regulatory Affairs Supervisor
Phone: (352) 273-5263
NCI Cancer Center badge